Large-scale gene expression analysis of human skeletal myoblast differentiation
暂无分享,去创建一个
Johan T. den Dunnen | Gert-Jan B. van Ommen | Ellen Sterrenburg | Rolf Turk | G. V. Ommen | J. T. Dunnen | R. Turk | J. Boer | E. Sterrenburg | Judith M. Boer | P. '. Hoen | J. Deutekom | Peter A.C. 't Hoen | Judith C.T. van Deutekom
[1] H. Green,et al. QUANTITATIVE STUDIES OF THE GROWTH OF MOUSE EMBRYO CELLS IN CULTURE AND THEIR DEVELOPMENT INTO ESTABLISHED LINES , 1963, The Journal of cell biology.
[2] Eric P Hoffman,et al. Slug Is a Novel Downstream Target of MyoD , 2002, The Journal of Biological Chemistry.
[3] D. Lawson,et al. Fibroblast transgelin and smooth muscle SM22alpha are the same protein, the expression of which is down-regulated in many cell lines. , 1997, Cell motility and the cytoskeleton.
[4] J. Martín,et al. Repression of myogenin function by TGF-beta 1 is targeted at the basic helix-loop-helix motif and is independent of E2A products. , 1992, The Journal of biological chemistry.
[5] Ling Lin,et al. Highly Coordinated Gene Regulation in Mouse Skeletal Muscle Regeneration* 210 , 2003, The Journal of Biological Chemistry.
[6] J. Nevins,et al. Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[7] T. Braun,et al. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. , 1989, The EMBO journal.
[8] H. Blau,et al. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy , 1994, The Journal of cell biology.
[9] F. Baas,et al. Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients. , 2003, Human molecular genetics.
[10] J. Massagué,et al. Type beta transforming growth factor is an inhibitor of myogenic differentiation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Rudnicki,et al. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. , 2002, Molecular cell.
[12] G. Prendergast,et al. A Role for the Putative Tumor Suppressor Bin1 in Muscle Cell Differentiation , 1998, Molecular and Cellular Biology.
[13] Voichita D. Marinescu,et al. Expression profiling and identification of novel genes involved in myogenic differentiation , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] K. Patel,et al. Muscle development genes: their relevance in neuromuscular disorders , 2002, Neuromuscular Disorders.
[15] H. Arnold,et al. Pax-3 is required for the development of limb muscles: a possible role for the migration of dermomyotomal muscle progenitor cells. , 1994, Development.
[16] M. Ffrench,et al. BTG1, a member of a new family of antiproliferative genes. , 1992, The EMBO journal.
[17] Floor de Kort,et al. Fluorescent labelling of cRNA for microarray applications , 2003 .
[18] Johan T den Dunnen,et al. GeneHopper: a web-based search engine to link gene-expression platforms through GenBank accession numbers , 2003, Genome Biology.
[19] D. Clegg,et al. Differential localization and functional role of calsequestrin in growing and differentiated myoblasts , 1995, The Journal of cell biology.
[20] P. Brown,et al. Exploring the metabolic and genetic control of gene expression on a genomic scale. , 1997, Science.
[21] Johan T den Dunnen,et al. A common reference for cDNA microarray hybridizations. , 2002, Nucleic acids research.
[22] Martin Vingron,et al. Variance stabilization applied to microarray data calibration and to the quantification of differential expression , 2002, ISMB.
[23] H. Weintraub,et al. Expression of a single transfected cDNA converts fibroblasts to myoblasts , 1987, Cell.
[24] B. Williams,et al. Pax-3 expression in segmental mesoderm marks early stages in myogenic cell specification. , 1994, Development.
[25] C. Auffray,et al. The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. , 1996, Genomics.
[26] L. Kunkel,et al. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[27] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[28] E. Olson,et al. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. , 1989, Genes & development.
[29] Harold Weintraub,et al. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins , 1990, Cell.
[30] T. Braun,et al. Myf‐6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12. , 1990, The EMBO journal.
[31] M. Yacoub,et al. Human cardiac troponin T: identification of fetal isoforms and assignment of the TNNT2 locus to chromosome 1q. , 1994, Genomics.
[32] E. Olson,et al. SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. , 1996, Circulation research.
[33] B. Wold,et al. Herculin, a fourth member of the MyoD family of myogenic regulatory genes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. Goulding,et al. Regulation of Pax-3 expression in the dermomyotome and its role in muscle development. , 1994, Development.
[35] B. Festoff,et al. Extracellular matrix synthesis by skeletal muscle in culture. Proteins and effect of enzyme degradation. , 1982, The Journal of biological chemistry.
[36] M. Rudnicki,et al. The molecular regulation of myogenesis , 2000, Clinical genetics.
[37] J. Ervasti,et al. Membrane organization of the dystrophin-glycoprotein complex , 1991, Cell.
[38] G. V. Ommen,et al. Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy , 2002, Neuromuscular Disorders.
[39] B. Black,et al. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins , 1995, Cell.
[40] S. Aaronson,et al. Basis for the Acquaisition of Malignant Potential by Mouse Cells Cultivated in vitro , 1968, Science.
[41] P. Jha,et al. Isolation and characterization of human fast skeletal beta troponin T cDNA: comparative sequence analysis of isoforms and insight into the evolution of members of a multigene family. , 1994, DNA and cell biology.
[42] Eric P. Hoffman,et al. Expression Profiling in the Muscular Dystrophies Identification of Novel Aspects of Molecular Pathophysiology , 2000 .
[43] Pumin Zhang,et al. Dynamic gene expression during the onset of myoblast differentiation in vitro. , 2003, Genomics.
[44] K. Patel,et al. The importance of timing differentiation during limb muscle development , 1998, Current Biology.
[45] Tatsushi Toda,et al. cDNA microarray analysis of individual Duchenne muscular dystrophy patients. , 2003, Human molecular genetics.
[46] K. Campbell,et al. Association of Triadin with the Ryanodine Receptor and Calsequestrin in the Lumen of the Sarcoplasmic Reticulum (*) , 1995, The Journal of Biological Chemistry.
[47] E. Oakeley,et al. 5-Methylcytosine DNA glycosylase participates in the genome-wide loss of DNA methylation occurring during mouse myoblast differentiation. , 2001, Nucleic acids research.
[48] A. McMahon,et al. Combinatorial signaling by Sonic hedgehog and Wnt family members induces myogenic bHLH gene expression in the somite. , 1995, Genes & development.
[49] G. Lanfranchi,et al. Identification of 4370 expressed sequence tags from a 3'-end-specific cDNA library of human skeletal muscle by DNA sequencing and filter hybridization. , 1996, Genome research.
[50] J. Sellers,et al. Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems. , 1991, The Journal of biological chemistry.